1. A comprehensive review on possibilities of treating psoriasis using dermal cyclosporine

   • Sonia Pandey
   • Purnima Tripathi
   • Jitendra Singh Yadav

   Review Article 22 September 2021 Pages: 1541 - 1555

   

2. Advances in microneedle-based transdermal delivery for drugs and peptides

   • Krishanu Aich
   • Tanya Singh
   • Shweta Dang

   ReviewPaper 26 September 2021 Pages: 1556 - 1568

   

3. A review on multivesicular liposomes for pharmaceutical applications: preparation, characterization, and translational challenges

   • Akash Chaurasiya
   • Amruta Gorajiya
   • Ajeet Kumar Singh

   Review Article 01 October 2021 Pages: 1569 - 1587

   

4. Polymeric magnetic nanoparticles: a multitargeting approach for brain tumour therapy and imaging

   • Bhavana Joshi
   • Abhijeet Joshi

   Review Article 19 September 2021 Pages: 1588 - 1604

   

5. An overview on tumor treating fields (TTFields) technology as a new potential subsidiary biophysical treatment for COVID-19

   • Ahmad Reza Farmani
   • Forough Mahdavinezhad
   • Nima Rezaei

   Review Article 20 September 2021 Pages: 1605 - 1615

   

6. Lipid-based emulsion drug delivery systems — a comprehensive review

   • Mori Dhaval
   • Poonam Vaghela
   • Ramesh Parmar

   Review Article 05 October 2021 Pages: 1616 - 1639

   

7. Appraisal of fluoroquinolone-loaded carubinose-linked hybrid nanoparticles for glycotargeting to alveolar macrophages

   • Priyanka Maurya
   • Ravi Saklani
   • Shubhini A. Saraf

   Original Article 03 September 2021 Pages: 1640 - 1658

   

8. In vitro release, ex vivo penetration, and in vivo dermatokinetics of ketoconazole-loaded solid lipid nanoparticles for topical delivery

   • Mohhammad Ramzan
   • Samuel Gourion-Arsiquaud
   • Indu Pal Kaur

   Original Article 07 January 2022 Pages: 1659 - 1683

   

9. The MEK 1/2 inhibitor PD98059 exhibits synergistic anti-endometrial cancer activity with paclitaxel in vitro and enhanced tissue distribution in vivo when formulated into PAMAM-coated PLGA-PEG nanoparticles

   • Kanawat Wiwatchaitawee
   • Aml I. Mekkawy
   • Aliasger K. Salem

   Original Article 11 October 2021 Pages: 1684 - 1696

   

10. A numerical study of the distribution of chemotherapeutic drug carmustine in brain glioblastoma

    • Hongyu Chen
    • Guanghui Hu
    • Defang Ouyang

    Original Article 14 October 2021 Pages: 1697 - 1710

    

11. A pharmacological approach assessing the role of mast cells in insulin infusion site inflammation

    • Shereen Kesserwan
    • Li Mao
    • Ulrike Klueh

    Original Article 24 September 2021 Pages: 1711 - 1718

    

12. Preclinical assessment of nanostructured liquid crystalline particles for the management of bacterial keratitis: in vivo and pharmacokinetics study

    • Shreya Kaul
    • Upendra Nagaich
    • Navneet Verma

    Original Article 28 September 2021 Pages: 1719 - 1737

    

13. Liposomal formulations of oxybutynin and resiniferatoxin for the treatment of urinary diseases: improvement of drug tolerance upon intravesical

    • Lorena M. D. Cirino
    • Daviane M. C. Vergne
    • Eliana B. Souto

    Original Article 20 October 2021 Pages: 1738 - 1752

    

14. Development of ritonavir-loaded nanostructured lipid carriers employing quality by design (QbD) as a tool: characterizations, permeability, and bioavailability studies

    • Vishal C. Gurumukhi
    • Sanjaykumar B. Bari

    Original Article 20 October 2021 Pages: 1753 - 1773

    

15. Hybridization of tumor homing and mitochondria-targeting peptide domains to design novel dual-imaging self-assembled peptide nanoparticles for theranostic applications

    • Syed Faheem Askari Rizvi
    • Samiah Shahid
    • Haixia Zhang

    Short Communication 17 September 2021 Pages: 1774 - 1785